PERIPHERAL EXUDATIVE HAEMORRHAGIC CHORIORETINOPATHY

PERIPHERAL EXUDATIVE HAEMORRHAGIC CHORIORETINOPATHY was reported 5 times

PERIPHERAL EXUDATIVE HAEMORRHAGIC CHORIORETINOPATHY is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Plasma Volume Expander [EPC] 1 0.0003
1 Complement Inhibitor [EPC] 1 0.0000
2 BCL-2 Inhibitor [EPC] 1 0.0000
3 Non-Standardized Chemical Allergen [EPC] 1 0.0000
4 Vascular Endothelial Growth Factor Inhibitor [EPC] 2 0.0000
5 Factor Xa Inhibitor [EPC] 1 0.0000
6 CD20-directed Cytolytic Antibody [EPC] 1 0.0000
7 HMG-CoA Reductase Inhibitor [EPC] 1 0.0000
8 Corticosteroid [EPC] 1 0.0000